Sonoma Pharmaceuticals (SNOA) Short term Debt (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Short term Debt of $222000.0 for Q1 2026, up 0.91% year-over-year from $220000.0 in Q1 2025, and up 296.43% quarter-over-quarter from $56000.0 in Q3 2025.
Sonoma Pharmaceuticals (SNOA) Short term Debt (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Short term Debt history runs 16 years deep, the most recent figure standing at $222000.0 for Q1 2026.
- In Q1 2026, Short term Debt rose 0.91% year-over-year to $222000.0; the TTM figure through Mar 2026 stood at $222000.0 (up 0.91% YoY), while the FY2026 annual figure was $222000.0, up 0.91% from the prior year.
- Short term Debt for Q1 2026 stood at $222000.0, up from $56000.0 in the prior quarter.
- The five-year high for Short term Debt was $688000.0 in Q1 2022, with the low at $44000.0 in Q4 2023.
- The 5-year median for Short term Debt is $221000.0 (2025), against an average of $255000.0.
- Peak annual rise in Short term Debt reached 15.44% in 2022, while the deepest fall reached 64.96% in 2022.
- Sonoma Pharmaceuticals' Short term Debt stood at $229000.0 in 2022, then tumbled by 80.79% to $44000.0 in 2023, then jumped by 86.36% to $82000.0 in 2024, then tumbled by 31.71% to $56000.0 in 2025, then jumped by 296.43% to $222000.0 in 2026.
- Business Quant data shows SNOA's Short term Debt at $222000.0 in Q1 2026, $56000.0 in Q3 2025, and $139000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 140,000.00 |
| Mar 31, 2026 | 222,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 220,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 204,000.00 |
| Mar 31, 2024 | 323,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 172,000.00 |
| Jun 30, 2023 | 301,000.00 |
| Mar 31, 2023 | 431,000.00 |
| Sep 30, 2022 | 229,000.00 |
| Jun 30, 2022 | 459,000.00 |
| Mar 31, 2022 | 688,000.00 |
| Dec 31, 2021 | 587,000.00 |
| Sep 30, 2021 | 587,000.00 |
| Jun 30, 2021 | 1.31 Mn |
| Mar 31, 2021 | 596,000.00 |
| Sep 30, 2020 | 49,000.00 |